A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.

Trial Profile

A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2015

At a glance

  • Drugs Somatropin (Primary)
  • Indications Growth disorders; Short stature
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NordiPAD
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 02 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 May 2015 Planned End Date changed from 1 Apr 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
    • 20 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top